rs1077182

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001849.4(COL6A2):​c.1521+21A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.163 in 1,611,126 control chromosomes in the GnomAD database, including 24,307 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1376 hom., cov: 33)
Exomes 𝑓: 0.17 ( 22931 hom. )

Consequence

COL6A2
NM_001849.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.648

Publications

7 publications found
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
COL6A2 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1B
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
  • Bethlem myopathy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 21-46121639-A-G is Benign according to our data. Variant chr21-46121639-A-G is described in ClinVar as Benign. ClinVar VariationId is 93908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.18 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A2NM_001849.4 linkc.1521+21A>G intron_variant Intron 18 of 27 ENST00000300527.9 NP_001840.3 P12110-1A0A384MDP3
COL6A2NM_058174.3 linkc.1521+21A>G intron_variant Intron 18 of 27 NP_478054.2 P12110-2
COL6A2NM_058175.3 linkc.1521+21A>G intron_variant Intron 18 of 27 NP_478055.2 P12110-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkc.1521+21A>G intron_variant Intron 18 of 27 1 NM_001849.4 ENSP00000300527.4 P12110-1
COL6A2ENST00000397763.6 linkc.1521+21A>G intron_variant Intron 18 of 27 5 ENSP00000380870.1 P12110-2
COL6A2ENST00000409416.6 linkc.1521+21A>G intron_variant Intron 17 of 26 5 ENSP00000387115.1 P12110-3
COL6A2ENST00000413758.1 linkc.144+21A>G intron_variant Intron 3 of 10 3 ENSP00000395751.1 H7C0M5

Frequencies

GnomAD3 genomes
AF:
0.118
AC:
17937
AN:
152088
Hom.:
1377
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0496
Gnomad AMI
AF:
0.0746
Gnomad AMR
AF:
0.0932
Gnomad ASJ
AF:
0.155
Gnomad EAS
AF:
0.0197
Gnomad SAS
AF:
0.0743
Gnomad FIN
AF:
0.0612
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.183
Gnomad OTH
AF:
0.130
GnomAD2 exomes
AF:
0.120
AC:
29797
AN:
247474
AF XY:
0.124
show subpopulations
Gnomad AFR exome
AF:
0.0490
Gnomad AMR exome
AF:
0.0691
Gnomad ASJ exome
AF:
0.157
Gnomad EAS exome
AF:
0.0245
Gnomad FIN exome
AF:
0.0625
Gnomad NFE exome
AF:
0.181
Gnomad OTH exome
AF:
0.140
GnomAD4 exome
AF:
0.168
AC:
244629
AN:
1458920
Hom.:
22931
Cov.:
33
AF XY:
0.165
AC XY:
119876
AN XY:
725834
show subpopulations
African (AFR)
AF:
0.0432
AC:
1445
AN:
33468
American (AMR)
AF:
0.0731
AC:
3269
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.161
AC:
4203
AN:
26120
East Asian (EAS)
AF:
0.0224
AC:
891
AN:
39690
South Asian (SAS)
AF:
0.0777
AC:
6699
AN:
86226
European-Finnish (FIN)
AF:
0.0680
AC:
3540
AN:
52076
Middle Eastern (MID)
AF:
0.155
AC:
894
AN:
5756
European-Non Finnish (NFE)
AF:
0.193
AC:
214249
AN:
1110590
Other (OTH)
AF:
0.157
AC:
9439
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
9582
19163
28745
38326
47908
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7296
14592
21888
29184
36480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.118
AC:
17941
AN:
152206
Hom.:
1376
Cov.:
33
AF XY:
0.111
AC XY:
8269
AN XY:
74396
show subpopulations
African (AFR)
AF:
0.0497
AC:
2066
AN:
41550
American (AMR)
AF:
0.0932
AC:
1425
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.155
AC:
537
AN:
3470
East Asian (EAS)
AF:
0.0198
AC:
102
AN:
5164
South Asian (SAS)
AF:
0.0737
AC:
356
AN:
4828
European-Finnish (FIN)
AF:
0.0612
AC:
649
AN:
10606
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.183
AC:
12430
AN:
67972
Other (OTH)
AF:
0.129
AC:
272
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
849
1698
2547
3396
4245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.151
Hom.:
379
Bravo
AF:
0.118
Asia WGS
AF:
0.0650
AC:
228
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 16, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
4.5
DANN
Benign
0.56
PhyloP100
0.65
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1077182; hg19: chr21-47541553; API